BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2019
View Archived Issues
CTC clusters affect methylation and metastasis
Read More
Iron transporter to the (retinal) rescue
Read More
Targeting transferrin receptor protein 2 knockout alleviates anemia in a model of beta-thalassemia
Read More
INTS1 gene variants tied to intellectual disability with eye defects and craniofacial anomalies
Read More
Comprehensive characterization of the GPCR nature of FZD5
Read More
In vitro studies interpret in vivo PK profile of S-012-1332
Read More
Phase II data for PF-04457845 as potential treatment of cannabis withdrawal and dependence
Read More
Osterix as a novel target for the control of bone metastasis in breast cancers
Read More
Phase I/II data presented from the PhagoBurn study of PP-1131
Read More
Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005
Read More
Bionor acquires HIV vaccine candidate Vacc-CRX from Immunor
Read More
Nash Pharmaceuticals reports preclinical activity and new compounds for kidney disease
Read More
New NATALEE trial tests ribociclib and endocrine therapy for HR+/HER2- early breast cancer
Read More
FDA approves Cabometyx for previously treated HCC
Read More
European approval for Opdivo with Yervoy for first-line intermediate- and poor-risk advanced RCC
Read More
City of Hope National Medical Center discovers poly(ADP-ribose) glycohydrolase inhibitors
Read More
Accro Bioscience patents necrosis inhibitors
Read More
Heat Biologics begins dosing in new phase II cohort of HS-110 with pembrolizumab for advanced NSCLC
Read More
Mining secondary metabolome yields anti-infective leads
Read More
New phase I trial to attack Alzheimer's by targeting inflammation in the brain's blood vessels
Read More
